CLINICAL_TRIALS
research
· 2025-12-11
Clinical Trial Update: Study of GC101 TIL in Brain Glioma (Soochow2) [EARLY_Phase 1]
Summary
A Phase 1 study evaluating GC101 TIL for glioma is currently recruiting, sponsored by Shanghai Juncell Therapeutics.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai Juncell Therapeutics | Conditions: Glioma | EARLY_Phase 1 | Status: RECRUITING